[Publication Report] Online Public Symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” Report (March 29, 2024)
date : 4/1/2024
Tags: Dementia
![[Publication Report] Online Public Symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” Report (March 29, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/dementia-20231212-top-1-1.png)
Health and Global Policy Institute (HGPI) has published the report of the online public symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” held on Tuesday, December 12, 2023.
As dementia risk becomes more connected to the individual, this symposium was held to provide an opportunity to consider how civil society should respond to the individualization of risk and what actions should be taken as a whole in order to build an inclusive society.
The symposium introduced ethical issues, the latest studies, and initiatives for dementia risk, including examples from overseas. We shared methods of approaching risks with society from the perspectives of industry, Government, academia, and civil society. In “dementia risk reduction, “we discussed who is it referring to when it says “those who want to (prevent dementia)” as specified in Article 21 of the Dementia Basic Act for Inclusive Society, and the significance of what is included in the Dementia Basic Act. We also deepen discussion on the need for and promotion of industry-academia/public-private collaboration, including how to utilize private sector technologies, products, and services in future dementia prevention efforts.
Based on the report of this symposium, we hope that the discussion on “dementia risk reduction” will be further deepened by domestic and international stakeholders.
[Event Overview]
- Date & Time: Tuesday, December 12, 2023; 17:00 – 20:30 JST
- Format: Online (Zoom Webinars)
- Language: Japanese and English, with simultaneous interpretation
- Participation fee: Free
- Host: Health and Global Policy Institute
- Sponsor:
Integra LifeSciences Corporation.
Splink,Inc.
Sompo Holdings, Inc.
National Graduate Institute for Policy Studies (GRIPS) Global Health Innovation Policy Program (GHIPP)
[Programme] (Titles omitted; in Japanese syllabary order)
17:00-17:05 | Opening remarks |
Hayato Suzuki (Member, House of Representatives / Executive Director, Parliamentary Association for Promoting Dementia Policies for an Inclusive Society) |
|
17:05-17:10 | Explanatory introduction |
Shunichiro Kurita (Senior Manager, HGPI) | |
Part1 | |
17:10-17:35 | Keynote lecture: Ethical Issues on the Individualization of Dementia Risk |
Shingo Segawa (Project coordinator and Researcher, Department of Medical Ethics and History of Medicine, University Medical Center Göttingen) | |
17:35-18:05 | Presentations: The Frontlines of Dementia Risk |
Building Evidence through Multifactorial Interventions Developing Communities to Foster Longevity |
|
Part 2 | |
18:10-19:20 | Presentations: Preparing for Dementia Risk as a Society |
From the perspective of industry: Necessary Steps to Develop Brain Health From the perspective of industry: Building and Providing a Comprehensive Support Package From the perspective of academia: Preventing Severe Complications Using Robots and Industry-Academia Collaboration From the perspective of academia: Transitioning from Individual Disease Prevention to Community-Building From the perspective of academia: A Form of Dementia that Improves with Treatment and Building Early Detection System From the perspective of civil society: Civil Society-Led Action to Prepare as a Society From the perspective of government: Improving Dementia in the *Me-Byo Stage |
|
19:30-20:30 | Discussion: How to Bear the Costs of Prevention and Health Promotion as a Society |
Panelists: Moderator: |
Top Research & Recommendations Posts
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Public Comment Submission] “GX2040 Vision (Draft)” (January 26, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Public Comment Submission] “Plan for Global Warming Countermeasures (Draft)” (January 26, 2025)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Publication Report] The Child Health Project Publishes Family Mental Health Booklet “Learning and Practicing at Home – Stress Management for Children with Intellectual Disabilities” (February 3, 2025)
- [Public Comment Submission] “Third Phase of The Healthcare Policy (Draft)” (February 3, 2025)
Featured Posts
-
2025-02-12
[Registration Open] (Webinar) The 131st HGPI Seminar “The Policy Process of the Kyoto City Caregiver Ordinance” (March 19, 2025)
-
2025-02-20
[Registration Open] The Cardiovascular Disease (CVD) Control Promotion Project Online Global Symposium “Exploring the Future of CVD Control Through Policy Case Studies in the Asia-Pacific Region” (March 13, 2025)
-
2025-03-03
[Registration Open] (Webinar) HGPI Special Seminar “Insights from Harvard Students on Fukushima’s Recover” (March 21, 2025 EDT | March 22, 2025 JST)
-
2025-03-13
[HGPI Policy Column] (No.54) From the Kidney Disease Control Promotion Project “The Promotion of Kidney Disease Measures Through Multi-Stakeholder Collaboration”
-
2025-03-13
[HGPI Policy Column] (No.55) From the Kidney Disease Control Promotion Project “What Is Required from a Patient Perspective for Continuity of Treatment for Chronic Kidney Disease (CKD): Dietary Therapy Edition”